*  Exposure Controls/Personal Protection  *
Respiratory Protection:NONE REQUIRED.
Ventilation:LOCAL EXHAUST.
Other Protective Equipment:PROTECTIVE COVERING
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
    REUSE. WASH THOROUGHLY AFTER HANDLING.
Supplemental Safety and Health
*  Product Identification  *
*  Composition/Information on Ingredients  *
Ingred Name:TRIACETIN
Fraction by Wt: 8%
OSHA PEL:6 MG/CUM
ACGIH TLV:0.2 MG/CUM
Fraction by Wt: <1%
Other REC Limits:0.5 UG/CUM
OSHA PEL:0.5 UG/CUM
ACGIH TLV:0.5 UG/CUM
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:NO  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:EYES/SKIN: IRRITATION.
    DINOPROSTONE-ADVERSE REPRODUCTIVE EFFECTS.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:DINOPROSTONE-INTENSE BRONCHOSPASM, INCREASED
    BONE FORMATION, NAUSEA, VOMITING, DIARRHEA, PYREXIA, HYPOTENSION.
Medical Cond Aggravated by Exposure:ANTIHYPERTENSIVE AGENT TREAMENT,
    ASTHMA, HISTORY OF ASTHMA/GLAUCOMA/INCREASED INTRAOCULAR PRESSURE,
    SEVERE RENAL/HEPATIC DYSFUNCTION, PREGNANCY.
*  First Aid Measures  *
    INHALATION: REMOVE TO FRESH AIR. OBTAIN MEDICAL ATTENTION IN ALL
    CASES.
*  Fire Fighting Measures  *
Flash Point:NON-FLAMMABLE
Extinguishing Media:WATER, CO2, DRY CHEMICAL.
Fire Fighting Procedures:WEAR SELF CONTAINED BREATHING APPARATUS & FULL
    BODY PROTECTIVE EQUIPMENT.
Unusual Fire/Explosion Hazard:NONE
*  Accidental Release Measures  *
Spill Release Procedures:PROVIDE VENTILATION/PERSONAL PROTECTIVE
    EQUIPMENT. KEEP PRODUCT OUT OF DRAINS & PREVENT ENTRY TO
    SURFACE/GROUNDWATER & SOIL. SMALL: ABSORB W/PAPER TOWELS/OTHER
    APPROPRIATE MEDIA. LARGE: VACUUM/SCOOP U P & PLACE IN SUITABLE
    CONTAINER. NEUTRALIZE AREA.
Neutralizing Agent:1:1 BLEACH & WATER.
*Handling and Storage  *
Other Precautions:AVOID CONTACT W/SKIN, EYES & CLOTHING. KEEP OUT OF
    REACH OF CHILDREN. PREGNANT FEMALES SHOULD AVOID DIRECT EXPOSURE TO
    THIS DRUG.
*  Physical/Chemical Properties  *
Appearance and Odor:STERILE SEMI-TRANSLUCENT GEL (0.5 MG DINOPROSTONE)
    IN 2.5 ML SYRINGE.
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
TRIACETIN-STRONG OXIDIZING AGENTS.
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:CO & CO2
*  Disposal Considerations  *
Waste Disposal Methods:DISPOSE OF BY INCINERATION IAW/INTERNATIONAL,
    FEDERAL, STATE & LOCAL REGULATIONS.
